The Week’s 10 Biggest Funding Rounds: Alumis Leads Big Biotech …

Mar 8, 2024 · March seems to be picking up where February left off as far as investors being more willing to write big checks for even bigger rounds. 1. Alumis, $259M, biotech: This week …

CouponFollow Extension

$259
OFF

The Week’s 10 Biggest Funding Rounds: Alumis Leads Big Biotech …

5 days from now

Mar 8, 2024 · March seems to be picking up where February left off as far as investors being more willing to write big checks for even bigger rounds. 1. Alumis, $259M, biotech: This week …

crunchbase.com

$259
OFF

The Week’s 10 Biggest Funding Rounds: Alumis Leads Big Biotech …

5 days from now

Dec 5, 2023 · The Week’s 10 Biggest Funding Rounds: Alumis Leads Big Biotech Week ... Alumis, $259M, biotech: This week saw the biggest biotech raise of the year thus far. South …

ainad.net

$259
OFF

The Week’s 10 Biggest Funding Rounds: Alumis Leads Big Biotech …

5 days from now

Mar 8, 2024 · The largest funding round was secured by Alumis, a biotech startup developing oral therapies for immune-mediated diseases, which raised a $259M Series C led by Foresite …

bestofai.com

$259
OFF

Alumis Dominates Big Biotech: Top 10 Weekly Funding Rounds

5 days from now

In the week of March 2 to 8, 2024, the top funding rounds in the U.S. were dominated by biotech companies. Alumis secured $259 million in Series C funding, making it the largest biotech …

funderlyst.com

$100
OFF

The Week’s 10 Biggest Funding Rounds: Alumis Leads Big Biotech …

5 days from now

Mar 8, 2024 · Want to keep track of the largest startup funding deals in 2024 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out

zephyrnet.com

$1
OFF

Biotech Booms With Massive Funding: U.S. Startups Secure Over $1 ...

5 days from now

Mar 8, 2024 · The U.S. saw a surge in big funding rounds, with biotech companies leading the way. Alumis raised $259 million, Axonius secured $200 million, and Sionna Therapeutics …

brief.news

$259
OFF

Alumis Raises $259M In 2024's Largest Biotech Round So Far - Fierce …

5 days from now

Mar 6, 2024 · Alumis has reeled in an eye-watering $259 million series C, financing that will help launch a phase 3 psoriasis trial for lead asset ... It marks the biggest haul for a private biotech …

fiercebiotech.com

$100
OFF

The Week’s 10 Biggest Funding Rounds: CleanCapital And …

5 days from now

Jun 9, 2023 · It was a big, big week in funding, with eight rounds topping $100 million and the top two totaling $700 million. Biotech and health care again saw several huge rounds — taking six …

crunchbase.com

$250
OFF

The Week’s 10 Biggest Funding Rounds: Biotech Leads The Way …

5 days from now

Nov 4, 2022 · 1. Emalex Biosciences, $250M, biotech: Biotech was big this week, and no bigger than the $250 million Series D raise biotech startup Emalex Biosciences locked up. Emalex …

crunchbase.com

$100
OFF

The Week’s Biggest Funding Rounds: XAI And Anthropic Headline …

5 days from now

1 day ago · Want to keep track of the largest startup funding deals in 2024 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase …

crunchbase.com

FAQs about The Week’s 10 Biggest Funding Rounds: Alumis Leads Big Biotech … Coupon?

Did biotech companies raise big rounds this week?

Even as venture capital funding has declined this year, biotech companies have been able to raise some big rounds — this week was no exception. Two of the top three rounds were raised by biotech startups, and other very traditional sectors including data integration and cyber saw big raises as investors turned to some old favorites. Search less. ...

Which Biotech has raised a $50 million round?

7. (tied) Twin Health, $50M, biotech: Mountain View, California-based Twin Health locked up a $50 million round led by Temasek. The company uses a body digital twin to reverse or prevent chronic metabolic diseases. Founded in 2018, the company has raised nearly $250 million, per Crunchbase. 10. ...

Will alumis fund a psoriasis trial?

Alumis has reeled in an eye-watering $259 million series C financing that will support a pipeline of oral therapies designed to tackle immune dysfunction and help launch a phase 3 psoriasis trial for lead asset ESK-001. It marks the biggest haul for a private biotech so far in 2024, according to Fierce Biotech’s Fundraising Tracker. ...

Which biotech companies have raised a lot of money?

1. Tome Biosciences, $213M, biotech: A big biotech raise hit high on the list this week. Watertown, Massachusetts-based Tome Biosciences emerged from stealth with a $213 million combination Series A and B funding from investors that include the likes of Andreessen Horowitz Bio + Health and Arch Venture Partners. ...

Which Biotech has a $250 million Series D raise?

1. Emalex Biosciences, $250M, biotech: Biotech was big this week, and no bigger than the $250 million Series D raise biotech startup Emalex Biosciences locked up. Emalex was started in 2018 by life science incubator Paragon Biosciences to create treatments for the central nervous system. ...

Should alumis go IPO?

The biotech is currently running discovery work for undisclosed immune-mediated diseases and targets identified by its data analytics platform. Looking ahead, Babler said Alumis is fortunate to have many opportunities for raising capital and that an IPO is one of many options to consider for the future. ...